Annexon Balance Sheet
NASDAQ: ANNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Annexon financial position
At the end of fiscal 2025, Annexon reported total assets of $277.6 million, down 20.7% from a year earlier against total liabilities of $65.9 million. Shareholders' equity stood at $211.6 million, or 76.3% of assets. The company held $162.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.68, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Annexon balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 162.05M | 49.50M | 225.11M | 140.02M | 74.84M | 268.56M | 43.93M |
| Short-Term Investments | 76.29M | 262.52M | 34.61M | 102.64M | 167.87M | 82.64M | — |
| Total Current Assets | 242.19M | 316.46M | 263.86M | 248.10M | 247.69M | 354.01M | 45.41M |
| Property, Plant & Equipment | 10.62M | 12.64M | 14.77M | 16.84M | 17.85M | 1.94M | 2.14M |
| Total Assets | 277.57M | 350.07M | 297.67M | 285.10M | 287.04M | 355.95M | 49.90M |
| Accounts Payable | 14.93M | 10.43M | 5.49M | 7.42M | 11.15M | 3.73M | 2.37M |
| Total Current Liabilities | 42.63M | 30.51M | 17.93M | 22.36M | 21.74M | 10.62M | 4.93M |
| Total Liabilities | 65.92M | 56.97M | 47.12M | 53.90M | 55.13M | 11.67M | 6.37M |
| Shareholders' Equity | 211.65M | 293.11M | 250.56M | 231.19M | 231.91M | 344.28M | -100.45M |
| Retained Earnings | -917.39M | -710.70M | -572.50M | -438.26M | -296.31M | -165.99M | -102.58M |
| Net Cash (Debt) | 238.34M | 312.02M | 259.72M | 242.66M | 242.72M | 351.21M | 43.93M |
| Shares Outstanding | 149.36M | 109.38M | 78.37M | 47.72M | 38.56M | 38.16M | 433.75K |
This table shows 7 annual periods of Annexon's balance sheet, from FY 2025 back to FY 2019, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ANNX's reporting calendar. What is a balance sheet?